Apollomics APLM
NASDAQ APLM
$22.05 +0.95 (+4.56%)
As of: Oct 19, 2026 · 12:55 PM EDT

Apollomics (APLM) Retained Earnings (2021 - 2025)

Updated

Apollomics (APLM) recorded Retained Earnings of -$711.76 million in Q4 2025, compared with -$700.82 million a year earlier.

Analysis

Apollomics (APLM) Retained Earnings (2021 - 2025) Analysis & Trends

Starting with Q4 2021, Apollomics' Retained Earnings history includes 9 quarters.

  • Across earlier years, Retained Earnings came in at -$700.82 million in FY2024, -$646.97 million in FY2023, -$474.6 million in FY2022 and -$235.44 million in FY2021.
  • Quarterly Retained Earnings has ranged from -$713.36 million in Q2 2025 to -$281,672 in Q2 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,132.02 Bn 1,100.60 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 613.16 Bn 531.69 Bn 17.26 Bn 171.67 Bn
3 AbbVie 503.74 Bn 476.85 Bn 12.70 Bn -17.33 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 297.66 Bn 261.65 Bn 11.24 Bn -
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn 12.59 Bn
7 Amgen 236.04 Bn 191.44 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 190.96 Bn 165.16 Bn 6.22 Bn 2.20 Bn
9 Pfizer 169.89 Bn 116.53 Bn 10.94 Bn 112.09 Bn
10 Apollomics 44.32 Mn 3.22 Mn - -711.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -711.80 Mn
Jun 30, 2025 -713.40 Mn
Dec 31, 2024 -700.82 Mn
Jun 30, 2024 -682.17 Mn
Dec 31, 2023 -646.97 Mn
Jun 30, 2023 -625.10 Mn
Dec 31, 2022 -474.60 Mn
Jun 30, 2022 -281,672.00
Dec 31, 2021 -235.44 Mn
API Access

Apollomics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=APLM&period=max&api_key=YOUR_API_KEY